Piper Sandler Maintains Organon & Co(OGN.US) With Buy Rating, Maintains Target Price $24
Organon & Co (OGN.US) will release its Earnings Reports before the market opens on May 1.
$Organon & Co (OGN.US) $ will release its Earnings Reports before the market opens on May 1, and investors are advised to pay attention. How were the previous performances? $Organon & Co (OGN.US) had revenue of 1.592 billion USD, Net income of 0.109 billion USD, and EPS of 0.42 USD in Q4 2024. In Q1 2024, the revenue was 1.622 billion USD, Net income was 0.201 billion USD, and EPS was 0.78 USD. The accounting standards used for the above data are US GAAP. Futubull reminder: 1. The accounting fiscal year division for Hong Kong and US listed companies.
TD Cowen Maintains Organon & Co(OGN.US) With Hold Rating, Cuts Target Price to $15
Research Alert: CFRA Keeps Sell View On Shares Organon & Co
Morgan Stanley Maintains Organon & Co(OGN.US) With Hold Rating, Maintains Target Price $15
BofA Securities Maintains Organon & Co(OGN.US) With Sell Rating, Announces Target Price $11
